Lv41
506 积分 2024-02-14 加入
Call for effective therapies for preventing dementia in people with type 2 diabetes
1小时前
待确认
A predictive model for the risk of cognitive impairment in community middle-aged and older adults
9天前
已完结
Development and validation of a machine learning model for early screening of high-risk mild cognitive impairment from the multi-cohort data
1个月前
已完结
Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis
4个月前
已完结
Multiple sclerosis and nephrolithiasis: a matched‐case comparative study
4个月前
已完结
Finnish multiple sclerosis patients treated with cladribine tablets: a nationwide registry study
4个月前
已完结
High persistence and low adverse events burden in cladribine treated MS patients from Argentina
4个月前
已关闭
Comparative safety of high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis
4个月前
已完结
Safety and Effectiveness of Cladribine in Multiple Sclerosis: Real-World Clinical Experience From 5 Tertiary Hospitals in Portugal
4个月前
已完结
Safety of high efficacy therapies in older people with Multiple Sclerosis: a real-world evidence study
4个月前
已关闭
皖公网安备34019202002308
